FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

30170611000001101: Naloxegol 25mg tablets 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Sep 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
93910501000001117 Naloxegol 25mg tablets 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
93910601000001118 Naloxegol 25mg tablets 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Naloxegol 25mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Naloxegol 25mg tablets 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Naloxegol 25mg tablets 30 tablet Has VMP Naloxegol 25mg tablets true Inferred relationship Existential restriction modifier
Naloxegol 25mg tablets 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Naloxegol 25mg tablets 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Naloxegol 25mg tablets 30 tablet Has specific active ingredient Naloxegol oxalate false Inferred relationship Existential restriction modifier
Naloxegol 25mg tablets 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Naloxegol 25mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Naloxegol false Inferred relationship Existential restriction modifier
Naloxegol 25mg tablets 30 tablet Has specific active ingredient Naloxegol oxalate true Inferred relationship Existential restriction modifier
Naloxegol 25mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Naloxegol true Inferred relationship Existential restriction modifier
Naloxegol 25mg tablets 30 tablet Has basis of strength substance Naloxegol true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Moventig 25mg tablets (AstraZeneca UK Ltd) 30 tablet 3 x 10 tablets Is a True Naloxegol 25mg tablets 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start